Onsior

RSS

robenacoxib

Authorised
This medicine is authorised for use in the European Union.

Overview

Onsior is an anti-inflammatory veterinary medicine for use in cats and dogs to treat pain and inflammation.

In cats, Onsior tablets are used to treat pain and inflammation associated with acute (short term) and chronic (long term) musculoskeletal disorders (problems with the muscles and bones) and to reduce moderate pain and inflammation associated with orthopaedic (bone) surgery. The solution for injection is used to treat pain and inflammation associated with orthopaedic or soft tissue surgery, such as neutering.

In dogs, Onsior tablets are used to treat pain and inflammation associated with chronic osteoarthritis (a long-term disease causing pain and inflammation in the joints) and soft tissue surgery. The solution for injection is used to treat pain and inflammation associated with orthopaedic or soft tissue surgery.

Onsior contains the active substance robenacoxib.

This EPAR was last updated on 26/02/2020

Authorisation details

Product details
Name
Onsior
Agency product number
EMEA/V/C/000127
Active substance
robenacoxib
International non-proprietary name (INN) or common name
robenacoxib
Species
  • Dogs
  • Cats
Anatomical therapeutic chemical veterinary (ATCvet) codes
QM01AH91
Publication details
Marketing-authorisation holder
Elanco GmbH
Revision
13
Date of issue of marketing authorisation valid throughout the European Union
16/12/2008
Contact address

Heinz-Lohmann-Str 4
27472 Cuxhaven
Germany

Product information

20/01/2020 Onsior - EMEA/V/C/000127 - II/0024/G

Contents

Please note that the size of the above document can exceed 50 pages.

You are therefore advised to be selective about which sections or pages you wish to print.

Pharmacotherapeutic group

  • Antiinflammatory and antirheumatic products, non-steroids

  • Coxibs

Therapeutic indication

Cats (tablets):

For the treatmentRelief of pain and inflammation associated with acute andor chronic musculo-skeletal disorders.

For the reduction of moderate pain and inflammation associated with orthopaedic surgery.

Dogs (tablets):

For the Ttreatment of pain and inflammation associated with chronic osteoarthritis.

For the treatment of pain and inflammation associated with soft tissue surgery.

Cats and dogs (solution for injection):

For the Ttreatment of pain and inflammation associated with orthopaedic or soft tissue surgery.

Assessment history

Changes since initial authorisation of medicine

How useful was this page?

Add your rating
Average
1 rating